ÄÚÈÝ·¢²¼¸üÐÂʱ¼ä : 2026/3/18 8:26:42ÐÇÆÚÒ» ÏÂÃæÊÇÎÄÕµÄÈ«²¿ÄÚÈÝÇëÈÏÕæÔĶÁ¡£
C.ÎÄ»¯·ÕΧ D.ÒÔÉ϶¼ÊÇ ²Î¿¼´ð°¸ £ºD
10 . ʤÈÎËØÖÊÀíÂ۵ıùɽģÐÍÊÇÖ¸Éç»á½ÇÉ«ºÍ×ÔÎÒÈÏʶÊÇÔÚ£¨£©
A.±ùÉÏÖ®ÖÐµÄ B.±ùɽ֮É쵀 C.±ùɽ֮Ï嵀 D.ÒÔÉ϶¼²»ÊÇ ²Î¿¼´ð°¸ £ºC
´ð°¸½âÎö£º ÔÝÎÞ
?ҩʦÔÚÃÀ¹úÒ©Æ·¸£Àû¹ÜÀíÖеļÛÖµ¿¼ÊÔ
1 . ÃÀ¹úµÄִҵҩʦ¿ÉÄÜÔÚÄÄЩµØ·½¹¤×÷
A.Ò½Ôº B.ÉçÇøÒ©·¿ C.¿ÆÑÐÔºËù D.ÒÔÉÏËùÓÐ ²Î¿¼´ð°¸ £ºD
2 . PBMµÄÈ«³ÆÊÇ
A.Public Benefit Management B.Pharmacy Benefit Management C.Pharmacy Business Management D.Public Benefit Manager ²Î¿¼´ð°¸ £ºB
3 . ҩʦ¿ÉÒÔÔÚOptumRxÄĸö²¿Ãʤ×÷
A.ÓʼÄÒ©Æ·²¿ B.×Éѯ²¿ C.Ô¤ÉóºË²¿ D.ÒÔÉÏËùÓÐ ²Î¿¼´ð°¸ £ºD
4 . ×Ô¶¯»¯»úÆ÷ÈË¿ÉÒÔÔÚOptumRxÄĸö²¿Ãżûµ½
A.ÓʼÄÒ©Æ·²¿ B.×Éѯ²¿
C.Ô¤ÉóºË²¿ D.ÒÔÉÏËùÓÐ ²Î¿¼´ð°¸ £ºD
5 . Õý³£µÄ´¦·½´¦ÀíÁ÷³ÌÊÇ
A.¼È룬½áË㣬ÉóºË£¬·¢Ò© B.¼È룬ÉóºË£¬½áË㣬·¢Ò© C.¼È룬ÉóºË£¬·¢Ò©£¬½áËã D.¼È룬·¢Ò©£¬½áË㣬ÉóºË ²Î¿¼´ð°¸ £ºB
6 . Ô¤Åú×¼ÓÐÄÄЩÀà±ð
A.½×ÌÝÖÎÁÆ B.ÊýÁ¿ÏÞÖÆ C.³¬´¦·½¼¯ÓÃÒ© D.ÒÔÉÏËùÓÐ ²Î¿¼´ð°¸ £ºD 7 . һλ²¡ÈË»¼Óбû¸Î£¬Genotype 1, Ò½Éú¼Æ»®Ê¹ÓÃHarvoniÖÎÁÆ£¬ÇëÎÊʲôÇé¿öÏÂÁƳÌΪ12 ÖÜ
A.²¡È˹ýȥδʹÓùý¸ÉÈÅËØÖÎÁÆ£¬²¡¶¾ÊýÁ¿ÉÙÓÚ6°ÙÍòµ¥Î»Ã¿ºÁÉý£¬ÎÞ¸ÎÓ²»¯ B.²¡È˹ýȥδʹÓùý¸ÉÈÅËØÖÎÁÆ£¬²¡¶¾ÊýÁ¿ÉÙÓÚ6°ÙÍòµ¥Î»Ã¿ºÁÉý£¬ÓиÎÓ²»¯ C.²¡È˹ýȥʹÓùý¸ÉÈÅËØÖÎÁÆÇÒ¸´·¢ÁË£¬²¡¶¾ÊýÁ¿ÉÙÓÚ6°ÙÍòµ¥Î»Ã¿ºÁÉý£¬ÓиÎÓ²»¯
D.ÒÔÉϽԲ»ÊÇ ²Î¿¼´ð°¸ £ºB
8 . ÒÔÏÂOptumRxµÄÄÄÒ»Ìõ¹æ¶¨£¬ÊôÓÚ½×ÌÝÖÎÁƵķ¶³ë
A.ʹÓÃRepatha֮ǰ£¬ÐèҪʹÓùýPraluent¶øÇÒʧ°ÜÁË
B.HumiraÖÎÁÆCrohn's Disease£¬Ã¿Á½ÖÜ×¢ÉäÒ»´Î£¬³¬¹ý24ÖÜÒԺ󣬿ÉÒÔÔö¼ÓΪÿÖÜÒ»´Î
C.ÈôÏ£ÍûProlia½µµÍÒ»¸ö¼Û¸ñÇø¼ä£¬²¡ÈËÐèҪʹÓùýBonivaÇÒʧ°ÜÁË D.ÒÔÉϾù²»ÊÇ
²Î¿¼´ð°¸ £ºA
9 . ÓÐЧ³É·ÖÏàͬ£¬ÄÄÒ»¸öÒ©¸üÓпÉÄܱ»ÅųýÔÚ±¨ÏúҩƷĿ¼֮Íâ
A.Naloxone×¢ÉäÒº B.Evzio
C.NarcanÅç±Ç¼Á D.ÒÔÉϾù²»ÊÇ ²Î¿¼´ð°¸ £ºB
10 . ÄÄÒ»¸öÒ©ÔÚMedicare±£Ïռƻ®ÖÐûÓб»ÍêÈ«½ûÖ¹±¨Ïú
A.Viagra 25 mg
B.Vitamin B-12 500 mcg C.Sildenafil 20 mg D.ÒÔÉϾù²»ÊÇ ²Î¿¼´ð°¸ £ºC
Ò»ÆðÁÄÁÄÐØÍ´ÄǵãÊ¿¼ÊÔ
1 . ÒÔÏÂÄÄÖÖ¼²²¡²»»áµ¼ÖÂÒªÃüµÄÐØÍ´
A.¼±ÐÔÐ£Èû B.¼±ÐÔÖ÷¶¯Âö¼Ð²ã C.¼±ÐÔ·Î˨Èû D.ÀßÈí¹ÇÑ× ²Î¿¼´ð°¸ £ºD
2 . ¼ø±ðÐØÍ´ÐèÒª´Ó²¡Ê·ÖªµÀÄãÏßË÷
A.ÐØÍ´µÄÓÕÒò B.ÐØÍ´µÄ²¿Î» C.ÐØÍ´µÄÐÔÖÊ D.ÒÔÉϾùÊÇ ²Î¿¼´ð°¸ £ºD
3 . ˺ÁÑÑùÐØÍ´ÔÚÄÄÒ»¸ö¼²²¡×î³£¼û
A.¼±ÐÔÐ£Èû B.·Î˨Èû C.Ö÷¶¯Âö¼Ð²ã D.ÕÅÁ¦ÐÔÆøÐØ ²Î¿¼´ð°¸ £ºC
4 . Õë¶ÔÒªÃüÐØÍ´µÄ¸¨Öú¼ì²éÓÐÄÄЩ
A.Ðĵçͼ
B.ÐØ²¿XÏ߯½Æ¬ C.³¬ÉùÐĶ¯Í¼ D.ÒÔÉϾùÊÇ
²Î¿¼´ð°¸ £ºD
5 . ÒÔÏÂÄÄÏî²»ÊÇÐÄÔ´ÐÔÐØÍ´µÄÌØµã
A.ÐØÍ´³ÖÐøÊ±¼äÒ»°ãΪÊý·ÖÖÓ»òÊ®¼¸·ÖÖÓ B.Ô˶¯/ÇéÐ÷¿ÉÒÔÓÕ·¢ÐØÍ´µÄ·¢Éú C.ÐØÍ´²¿Î»Óд¥Í´»òѹʹ D.Ðĵçͼ»òÐļ¡Ã¸Ñ§ÓÐ¸Ä±ä ²Î¿¼´ð°¸ £ºC
6 . Ðĵçͼ¼ì²é¶ÔÓÚÒÔÏÂÄĸö¼²²¡Ã»ÓÐÖ¸µ¼ÒâÒå
A.¼±ÐÔÐĽÊÍ´ B.¼±ÐÔÐ£Èû C.Ö÷¶¯Âö¼Ð²ã D.¼±ÐÔ·Î˨Èû ²Î¿¼´ð°¸ £ºC
7 . ÐØÍ´×î³£¼û²¡ÒòΪ
A.¼±ÐÔÐĹ£¡¢¼±ÐÔÐĽÊÍ´ B.·ÇÐÄÔ´ÐÔÐØÍ´ C.Ö÷¶¯Âö¼Ð²ã D.¼±ÐÔ·Î˨Èû ²Î¿¼´ð°¸ £ºA
8 . ÒÔÏÂ˵·¨ÕýÈ·µÄÊÇ
A.Ö÷¶¯Âö¼Ð²ãͨ³£·¢ÉúÔÚÓиßѪѹ»ò½áµÞ×éÖ¯¼²²¡£¨ÈçÂí·²×ÛºÏÕ÷£©»¼Õß B.·Î˨Èû»¼ÕßÍùÍù´æÔÚ×óÐÄÐÔ¡¢·ÎÔ´ÐÔ»ò·ÎѪ¹Ü±¾ÉíµÈ»ù´¡¼²²¡
C.Ð£Èû¶à°éÓÐÎüÑÌ¡¢¸ßѪѹ¡¢¸ßѪ֬¡¢ÌÇÄò²¡¡¢·ÊÅÖ¼°´úлÎÉÂÒ×ÛºÏÕ÷µÈ¼²²¡
D.ÒÔÉÏ˵·¨¾ùÕýÈ· ²Î¿¼´ð°¸ £ºD
9 . ¹ØÓÚÐØÍ´µÄÖÎÁÆ£¬´íÎóµÄ˵·¨ÊÇ
A.Ò»µ©»³ÒÉÐĹ££¬×¢ÒâÐÄÂÊ¡¢ÑªÑ¹¡¢ºôÎüÇé¿ö£¬Èò¡È˾²ÎÔ B.¿É½À·þ°¢Ë¾Æ¥ÁÖ
C.Èç¹û»³ÒÉÊǼ±ÐÔÖ÷¶¯Âö¼Ð²ã£¬ÌرðÐèÒª¼à²âѪѹ£¬×î´óÏ޶Ƚ«ÑªÑ¹½µÖÁ120/90mmHgΪÒË
D.Èç¹û»³ÒÉÊÇÆøÐØ£¬³ýÁË×¢Ò⻼ÕßÐÄÂÊ¡¢ÑªÑ¹¡¢ºôÎüÇé¿öÍ⣬¸ù¾ÝÇé¿ö¾¡¿ì¸øÓè´©´ÌÒýÁ÷»òÕß¾¡¿ìתÓÐÌõ¼þµÄÒ½Ôº½øÒ»²½ÖÎÁÆ ²Î¿¼´ð°¸ £ºC
10 . ÒÔÏÂÄÄÏîÊôÓÚµäÐ͵ÄÐ£ÈûÐĵçͼ±íÏÖ
A.¹ÚÂöÖ§ÅäÇøÓòµ¼ÁªµÄST¶Î¹±³ÏòÉÏ̧¸ß B.ÐĵçͼÔÚV1µ¼Áª³öÏÖQr C.V1-V4µÄµ¼ÁªµÄT²¨µ¹Öà D.ÒÔÉϾùÊÇ ²Î¿¼´ð°¸ £ºA
Ò½ÔºÒ©ÊÂÖÊÁ¿¿ØÖƲßÂÔ¿¼ÊÔ
µ¥Ñ¡Ì⣨¹² 10 Ì⣬ÿÌâ 10 ·Ö£©
1 . ҩʹÜÀíÖÊÁ¿¿ØÖÆ×÷ÓðüÀ¨£¨£© A.¹æ·¶Ò½ÔºÒ©Æ·åàÑ¡²É¹ºÁ÷³Ì B.¼ÓÇ¿ÁÙ´²Ò©Æ·Ó¦ÓÃÆÀ¼Û C.Ìá¸ßºÏÀíÓÃҩˮƽ D.ÒÔÉ϶¼ÊÇ ²Î¿¼´ð°¸ £ºD
2 . Ò©Æ·²É¹º¹«Ë¾µÄÉóºË°üÀ¨£¨£© A.ÆóÒµ¾ÓªÐí¿ÉÖ¤ B.ÓªÒµÖ´ÕÕ C.ÍøÉÏÉóºË D.ÒÔÉ϶¼ÊÇ ²Î¿¼´ð°¸ £ºD
3 . Ò©¼Á¿ÆÖÊÁ¿²¿ÃÅ£¨£©¶ÔÒ©Æ·²É¹ºÎļþ¼Ç¼½øÐÐÉó²é A.ÿÔ B.ÿ2Ô C.ÿ¼¾¶È D.ÿ°ëÄê ²Î¿¼´ð°¸ £ºB 4 . ҩʹÜÀíÖÊÁ¿¿ØÖÆÄÚÈݰüÀ¨²É¹ºÖÊÁ¿¿ØÖÆ¡¢Ò©·¿ÖÊÁ¿¿ØÖÆ¡¢Âé×í¡¢¾«Éñ£¬ÌØÊâÒ©Æ·ÖÊÁ¿¿ØÖÆ£»²»°üÀ¨£¨£© A.ÁÙ´²Ò©Ñ§ÖÊÁ¿¿ØÖÆ B.ÅäÒºÖÐÐÄÖÊÁ¿¿ØÖÆ C.Ò½ÁÆÊ¹ʱ¨¸æ D.ÒÔÉ϶¼ÊÇ ²Î¿¼´ð°¸ £ºC
5 . ²»Á¼·´Ó¦¼à²âºÍ±¨¸æÊôÓÚ£¨£©µÄ¹¤×÷ÄÚÈÝ A.¾²Âöµ÷ÅäÖÐÐÄÖÊÁ¿¿ØÖÆ